Diving into the labyrinth of intertwined dreams in Christopher Nolan’s Inception—where each dream level operates under its own rules while influencing the others—sharply illuminates the intricate…
Like Corto Maltese charting forgotten seas, the UK now sails through uncertain waters in the shifting landscape of European patent litigation. Brexit did not bring about a complete rupture but rather…
Yesterday, I shared some early figures from the UPC Court of Appeal, offering a glimpse into how the Court operates two years after its launch. But those reflections lingered long after I closed my…
Introduction: A Concert Interrupted
Imagine a Rammstein concert—tight rhythms, explosive precision, and overwhelming power. That’s what many expected from the German divisions of the UPC: efficiency,…
The Court of Appeal’s judgment in Optis Cellular Technology LLC v Apple Retail UK Ltd [2025] EWCA Civ 552, handed down on 1 May 2025, is arguably the most significant UK FRAND decision since Unwired…
In the UK, as well as in many other countries, being the first to market with a generic or biosimilar to a leading branded medicine is a critical strategy that can offer a major advantage to a…
In a decision rendered on 12 June 2024, the full chamber of the private law division (‘Segunda Seção’) of the Brazilian Superior Court of Justice ruled that state courts may decide on the validity of…
Background
In June 2024, we reported that in an application for provisional measures brought by Abbott Diabetes Care against Sibio Technology, The Hague Local Division (“LD”) determined, inter alia,…
A recent decision from Joanna Smith J dealing with the costs of a withdrawn application in a case before the English Patents Court contains an important postscript and suggests that the rules in the…
